Literature DB >> 7527888

Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease.

M B Youdim1, L Lavie.   

Abstract

In the absence of identification of either an endogenously or an exogenously derived dopaminergic neurotoxin, the most valid hypothesis currently envisaged for etiopathology of Parkinson's disease (PD) is selective oxidative stress (OS) in substantia nigra (SN). Although OS is not proven, a significant body of evidence from studies on animal and Parkinsonian brain neurochemistry supports it. This hypothesis is based on excessive formation of reactive oxygen species (O2 and OH.) and demise of systems involved with scavenging or preventing the formation of such radicals from H2O2, generated as a consequence of dopamine oxidation (autoxidation and deamination). Since MAO (monoamine oxidase A and B are the major H2O2 generating enzymes in the SN much attention has been paid to their selective inhibitors as symptomatic and neuroprotective agents in PD. Attention should also be given to radical scavengers (e.g. iron chelators, lipid peroxidative inhibitors and Vitamin E derivatives) as therapeutic neuroprotective agents in PD. This is considered valid since a significant elevation of iron is known to occur selectively in SN zone compacta and within the remaining melanized dopamine neurons of Parkinsonian brains. Although all the mechanism of iron induced oxygen free radical formation is not fully known there is no doubt that it participates with H2O2 (Fenton chemistry) to generate cytotoxic hydroxyl radical (OH.) and induce tissue OS and neurodegeneration in 6-hydroxydopamine model of PD. The dramatic proliferation of reactive amoeboid macrophages and microglia seen in SN of PD brains together with OS is highly compatible with an inflammatory process, similar to what has been observed in Alzheimer's disease and multiple sclerosis brains. This has led us to examine the ability of reactive macrophages to produce oxygen free radicals in response to nitric oxide (NO) production. The latter radical has been implicated in the excitotoxicity of glutaminergic neurons innervating the striatum and SN. Indeed we have now observed that in reactive macrophages NO acts as a signal transducer of O2 production which can synergize with dopamine oxidation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527888     DOI: 10.1016/0024-3205(94)00388-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Ethanol increases TIEG2-MAO B cell death cascade in the prefrontal cortex of ethanol-preferring rats.

Authors:  Xiao-Ming Ou; Chandra Johnson; Deyin Lu; Shakevia Johnson; Ian A Paul; Mark C Austin; Abiye H Iyo; Jose Javier Miguel-Hidalgo; Jia Luo; Richard L Bell; Matthew Grunewald; Junming Wang; Donald B Sittman
Journal:  Neurotox Res       Date:  2010-03-05       Impact factor: 3.911

2.  Cytoprotection of pyruvic acid and reduced beta-nicotinamide adenine dinucleotide against hydrogen peroxide toxicity in neuroblastoma cells.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Neurochem Res       Date:  2003-05       Impact factor: 3.996

3.  Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells.

Authors:  Marta Biagioli; Milena Pinto; Daniela Cesselli; Marta Zaninello; Dejan Lazarevic; Paola Roncaglia; Roberto Simone; Christina Vlachouli; Charles Plessy; Nicolas Bertin; Antonio Beltrami; Kazuto Kobayashi; Vittorio Gallo; Claudio Santoro; Isidro Ferrer; Stefano Rivella; Carlo Alberto Beltrami; Piero Carninci; Elio Raviola; Stefano Gustincich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

4.  Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.

Authors:  Luigi Stella; Vito De Novellis; Maria Redenta Vitelli; Annalisa Capuano; Filomena Mazzeo; Liberato Berrino; Francesco Rossi; Amelia Filippelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-17       Impact factor: 3.000

Review 5.  Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors:  Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.

Authors:  Tatyana D Sotnikova; Jean-Martin Beaulieu; Larry S Barak; William C Wetsel; Marc G Caron; Raul R Gainetdinov
Journal:  PLoS Biol       Date:  2005-08-02       Impact factor: 8.029

7.  Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors.

Authors:  Derya Osmaniye; Berkant Kurban; Begüm Nurpelin Sağlık; Serkan Levent; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2021-11-02       Impact factor: 4.411

8.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

9.  The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD.

Authors:  HyunHee Park; Kyung-Min Han; Hyongjun Jeon; Ji-Soo Lee; Hyunju Lee; Seong Gak Jeon; Jin-Hee Park; Yu Gyung Kim; Yuxi Lin; Young-Ho Lee; Yun Ha Jeong; Hyang-Sook Hoe
Journal:  Cells       Date:  2020-08-28       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.